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Abstract
Since the sample size of a typical neuroimaging study lacks sufficient statistical power to explore unknown
genomic associations with brain phenotypes, several international genetic imaging consortia have been
organized in recent years to pool data across sites. The challenges and achievements of these consortia are
considered here with the goal of leveraging these resources to study addiction. The authors of this review have
joined together to form an Addiction working group within the framework of the ENIGMA project, a meta-
analytic approach to multisite genetic imaging data. Collectively, the Addiction working group possesses
neuroimaging and genomic data obtained from over 10,000 subjects. The deadline for contributing data to the
first round of analyses occurred at the beginning of May 2015. The studies performed on this data should
significantly impact our understanding of the genetic and neurobiological basis of addiction.
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Abstract 
Since the sample size of a typical neuroimaging study lacks sufficient statistical power to explore 
unknown genomic associations with brain phenotypes, several international genetic imaging consortia 
have been organized in recent years to pool data across sites. The challenges and achievements of these 
consortia are considered here with the goal of leveraging these resources to study addiction. The 
authors of this review have joined together to form an Addiction working group within the framework of 
the ENIGMA project, a meta-analytic approach to multi-site genetic imaging data.  Collectively, the 
Addiction working group possesses neuroimaging and genomic data obtained from over 10,000 subjects. 
The deadline for contributing data to the first round of analyses occurred at the beginning of May 2015. 
The studies performed on this data should significantly impact our understanding of the genetic and 
neurobiological basis of addiction.  
 
Introduction 
The emergence of numerous large-scale international genetic imaging consortia in recent years is the 
product of several rapidly evolving factors. The maturing field of neuroimaging has made significant 
progress towards adopting a widely accepted set of best-practices which have been incorporated into 
several competing software distributions (e.g. SPM, AFNI, FreeSurfer, FSL) that are free to download and 
relatively easy to install. Adaptation of imaging software to the developing needs of the neuroimaging 
community and greater automation have been accompanied by tremendous efforts to annotate the 
software and to educate a large cadre of scientists who are now able to apply these methods to studies 
with increasingly large sample sizes. Evidence of these efforts can readily be found on the busy message 
boards of any of the major neuroimaging platforms. Furthermore, with the development of standard 
anatomical templates and coordinate-based reference systems, researchers worldwide can now relate 
their findings to previous results in a consistent way. In combination, these factors have facilitated the 
formation of several large-scale collaborations to overcome the limitation of small sample sizes in typical 
genetic imaging studies.  
The high dimensionality of genetic imaging datasets poses a difficult set of challenges. Human 
DNA consists of approximately 3 billion nucleotide base pairs. Variation in the population at any 
individual base is called a single nucleotide polymorphism (SNP) and may contribute to the differential 
expression of phenotypic traits. Genomic studies have become a medical research priority because the 
identification of the genetic variation associated with a disease helps to clarify its molecular basis which, 
in turn, should lead to improved diagnostic categorization and more effective treatments (Sullivan et al., 
2012). One way to proceed in identifying such associations is to investigate the relationship of traits of 
interest with candidate SNPs that are suggested on the basis of previous research (e.g. to examine the 
association of smoking behavior with SNPs related to the expression of nicotinic receptor subtypes). 
However, such a targeted approach is unlikely to expose the full range of SNPs involved in complex 
traits, such as addiction. To discover unknown trait-SNP associations, an unbiased search across the 
whole genome, known as a genome-wide association study (GWAS), is necessary. This latter strategy 
commonly involves testing hundreds of thousands to millions of SNPs and requires a strict multiple 
comparisons correction threshold, conventionally p ≤ 5x10-8, to avoid reporting spurious results. 
Furthermore, findings must be replicated in at least one independent cohort before they are considered 
credible or at least generalizable. To meet these stringent thresholds, sharing data across multiple sites 
has become necessary.  
There are now many successful examples of genetic imaging consortia, including ADNI 
(Alzheimer’s disease), IMAGEN (mental health and risk taking behavior in teenagers), EPIGEN (epilepsy), 
the Saguenay Youth Study (development), fBIRN (schizophrenia), and CHARGE (heart and ageing). These 
groups have pioneered the use of multi-site data sharing protocols and have demonstrated that 
analyses using shared data produce meaningful findings. The purpose of this review is to discuss how 
these resources can be leveraged to study addiction.  
 
Genetic Basis of Addiction 
It is clear that addiction has a genetic component (Maes et al., 2004; Prescott and Kendler, 1999; Tsuang 
et al., 1998) although the specific set of genes involved remains obscure. Several GWAS of alcohol 
addiction have been published (Bierut et al., 2010; Edenberg et al., 2010; Heath et al., 2011; Treutlein et 
al., 2009) which have confirmed the risk of alcoholism associated with of a number of SNPs, such as the 
ADH and ALDH2 genes, previously identified through the candidate gene approach. These studies have 
also identified some additional but as yet unreplicated variants that may contribute to alcohol 
dependence (Rietschel and Treutlein, 2013). However, results have largely differed from one GWAS to 
another with later studies providing only modest evidence of replication of previous findings. A similar 
situation exists with regard to cannabis in that published GWAS have not reproduced previous findings 
(Agrawal et al., 2011; Han et al., 2012; Hopfer et al., 2007). The genetic basis of nicotine dependence has 
been more closely examined than other substance addictions, although again only a handful of results 
have been replicated across studies (Berrettini et al., 2008; Drgon et al., 2009; Gelernter et al., 2015; 
Thorgeirsson et al., 2008; Uhl et al., 2008b; Wang et al., 2012a; Zuo et al., 2013). Only a few published 
GWAS have examined the genetic basis of other drug use (e.g. (Uhl et al., 2008a)). In summary, most of 
the genetic variation underlying addiction remains to be explained.  
  
Brain Endophenotypes  
The failure to identify a greater proportion of risk genes is disappointing given the high heritability of 
addiction. Recent estimates of the heritability of dependence on different addictive substances include: 
56% for alcohol, 72% for cocaine, 40% for other stimulants, 48% for cannabis, and 51% for sedatives 
(Bienvenu et al., 2011). The intermediate “endophenotypes” approach may be a more sensitive way to 
determine how genes influence addiction vulnerability (Glahn et al., 2014; Glahn et al., 2007). An 
intermediate endophenotype is a quantifiable biomarker (e.g. regional brain volume or activity) that is 
genetically correlated with disease liability and observed to a greater degree in affected individuals and 
their relatives than in unaffected non-relatives. Since these biomarkers are arguably more proximal to 
the molecular expression of DNA than the related complex trait, it may be possible to generate simpler 
models of single aspects of the disorder to effectively bridge the gap in understanding between 
genotype and phenotype. In addition, the statistical power to detect genetic associations may be greater 
than using diagnostic categories because intermediate endophenotypes represent a continuous scale on 
which individuals can be ranked. 
At least three lines of evidence suggest that genetic neuroimaging may produce useful 
intermediate endophenotypes of addiction. First, 20 years of neuroimaging data amply demonstrate 
that brain structure and function interact with the use of addictive substances. For example, brain 
structure differences compared to healthy controls have been observed in cocaine dependent 
individuals (Alia-Klein et al., 2011; Barros-Loscertales et al., 2011; Connolly et al., 2013; Hanlon et al., 
2011; Ide et al., 2014; Mackey and Paulus, 2013; Matochik et al., 2003), cigarette smokers (Brener et al., 
1995; Kuhn et al., 2010; Sutherland et al., 2013; Zhang et al., 2011) alcoholics (Cardenas et al., 2007; 
Jernigan et al., 1991; Rando et al., 2011), cannabis users (Batalla et al., 2013; Lorenzetti et al., 2014; 
Schacht et al., 2012; Yucel et al., 2008), and opiate users (Lyoo et al., 2006; Upadhyay et al., 2010; Wang 
et al., 2012b). These effects are widespread and likely reflect a mixture of pre-existing differences that 
either confer vulnerability to addiction or are the cumulative effects of chronic exposure.  
A second line of evidence suggesting that neuroimaging will generate useful intermediate 
phenotypes are twin and SNP-based heritability studies which indicate a high heritability for structural 
brain measures, such as total amount of gray and white matter, overall brain volume, and addiction-
relevant subcortical regions. Heritability estimates for brain measures (h
2
) are as high as 0.89 (Kremen et 
al., 2010) or even 0.96 (van Soelen et al., 2012) and subcortical regions appear to be moderately to 
highly heritable. One recent study reported high heritability estimates for the thalamus (0.80) and 
caudate nucleus (0.88) compared to a lower heritability for the left nucleus accumbens (0.44) (den 
Braber et al., 2013). 
Third, biomarkers of addiction which are present to a greater degree in affected individuals and 
their relatives compared to unaffected non-relatives have been reported. For example, a recent 
neuroimaging study acquired anatomical MRI and diffusion tensor image (DTI) scans in 50 biological 
sibling pairs and a group of non-related control subjects (Ersche et al., 2012). One sibling in each pair 
was dependent on cocaine or amphetamine. Fractional anisotropy in the DTI scans, an index of axonal 
integrity, was lower in dependent subjects and their non-dependent siblings compared to the control 
subjects. Also, voxel-based morphometry indicated that grey matter volume in both dependent subjects 
and their siblings was lower in left posterior Sylvian fissure including parts of the postcentral gyrus, 
insula, and superior temporal gyrus and higher in the left putamen and left amygdala. The discovery of 
biomarkers that are quantifiably different in drug dependent individuals and their siblings compared to 
non-related controls underscores the potential for neuroimaging to detect intermediate brain 
endophenotypes that will be useful in genomic research.  
 
Challenges 
The search for robust genetic and brain structural correlates of drug use and dependence faces a 
number of substantial challenges. The inability to find extensive significant genome-wide associations 
might be attributable to the large degree of heterogeneity due to polydrug use and the high incidence of 
mental health co-morbidities among drug users. It will be necessary to disambiguate several sources of 
genetic variation. Epidemiological studies indicate that there will be genetic variation associated with a 
general vulnerability to addiction and to a lesser extent drug specific associations as well as gene-
environment interactions (Tsuang et al., 1998). Furthermore, lifetime drug use can be decomposed into 
a number of qualitatively different stages (e.g. initial experimentation, occasional use, transition to 
abuse and dependence, risk of relapse) that current research indicates will exhibit different sets of 
genetic associations (Belin and Deroche-Gamonet, 2012; Everitt and Robbins, 2013; Montigny et al., 
2013). GWAS and candidate gene analyses also have their own unique shortcomings. While GWAS 
searches the whole genome for unknown associations, it will miss variants with small effect sizes that 
would pass the less stringent probability threshold of the candidate gene approach (Gizer and Ehlers, 
2015). With the candidate gene approach, however, there is no way to verify whether published 
candidate gene studies are systematically biased towards reporting successes. To correct for this latter 
problem it has even been suggested that candidate gene associations should be held to the same 
significance criterion as GWAS (Flint and Munafo, 2013). The solution will likely require a combination of 
the two search strategies to iteratively approximate the genetic polymorphisms involved in addiction 
using both intermediate endophenotypes and well-defined behavioral traits.   
 
Enhancing Neuro-Imaging Genetics through Meta-Analysis (ENIGMA) 
In 2009, researchers from large-scale neuroimaging and genetics consortia, including IMAGEN, EPIGEN, 
SYS, FBIRN, and ADNI, formed the Enhancing Neuroimaging Genetics through Meta-Analysis (ENIGMA) 
project to work through the challenges of bringing together data from multiple samples and sites 
worldwide in a single meta-analytic framework (http://enigma.ini.usc.edu/) (Thompson et al., 2014). 
The first published ENIGMA meta-analysis reported that the mean bilateral volume of the hippocampus 
was significantly associated with the intergenetic variant rs7294919 (Stein et al., 2012). This proof-of-
principle study established the feasibility of combining imaging and genomic data collected across 
multiple sites to investigate statistically significant effects of single letter genomic differences in brain 
data. In addition, a follow-up study discovered 8 genetic loci in which common variants were associated 
with the volumes of several subcortical structures, including the putamen, caudate, and hippocampus 
(Hibar et al., 2015). The SNPs associated with subcortical brain volumes were supported across 50 
cohorts worldwide, suggesting the power to identify genetic effects that account for as little as 1% of 
the variance in regional brain volumes. Functional characterization of these genetic loci, in outbred 
mice, was consistent with possible effects on cell number and links to degenerative disease risk 
(Ashbrook et al., 2014). The protocol developed by the ENIGMA network to harmonize the data from 
multiple sites has been made freely available to collaborators and a support structure based in Dr. Paul 
Thompson’s Imaging Genetics Center at the University of Southern California has been created to 
facilitate the application of the protocol to other projects.   
The ENIGMA protocol contains several innovations to deal with special issues arising from multi-
site analyses, notably imputation of genomic data to a common reference panel and a pathway to 
harmonize neuroimaging data with standardized quality control procedures. For the initial ENIGMA 
study, all data were imputed to the HapMap3 reference panel because SNP data at the various sites 
were genotyped on different gene chips. The imputation protocol adds substantial power to the overall 
meta-analysis by creating a genomic dataset that is comparable across sites and by employing state-of-
the-art approaches to account for hidden structure (e.g. ancestry) and relevant quality control variables. 
More recently, the ENIGMA imputation protocol implemented in MaCH 
(http://csg.sph.umich.edu/abecasis/MaCH/) has been updated to use the 1000 Genomes reference, a 
more in-depth analysis of the genome. To control for population stratification, multi-dimensional scaling 
(MDS) is applied to the genotyped data and the first four components are included as nuisance 
covariates in subsequent GWAS analyses (Hibar et al., 2015; Stein et al., 2012).  
 To process the neuroimaging data efficiently, one of two highly automated neuroimaging 
software packages (FSL’s FIRST and FreeSurfer) were used for the initial ENIGMA publications although 
in future studies, including those undertaken by the Addiction working group, only FreeSurfer (Fischl et 
al., 2002) will be employed (Figure 1). The use of these standard software programs ensures the 
comparability of neuroimaging results across sites. Despite the automation of FreeSurfer, considerable 
time is still required to test for statistical outliers, inspect distributions of brain structure volumes, 
genomic inflation factors and other statistical summaries at each site. 
Rather than using an analysis strategy where all phenotypic and genotypic data are sent to one 
central site for processing, as for example in the Psychiatric Genomics Consortium 
(http://www.med.unc.edu/pgc), ENIGMA employs a meta-analytic strategy in which GWAS are 
computed locally using agreed upon covariates. The advantages of this approach include the active 
involvement in the analysis of the researchers who collect and curate the data, and the ability to draw 
upon local computer infrastructure at each site to ease demand on central data processing. Site level 
GWAS are performed with Mach2qtl, a statistical genetics algorithm developed by Goncalo Abecasis and 
colleagues (Li et al., 2010). Multiple linear regression is performed on each SNP using trait as the 
dependent variable and allelic dosage (i.e. 0, 1, or 2 alleles) as the independent variable of interest. Sites 
control for a set of basic nuisance factors, namely the first four MDS components, age, sex, age*sex 
interaction effects, and nonlinear effects of age, including age2 and age2*sex, by adding them as 
covariates in the regression model. Site-specific covariates may also be added (e.g. if data are acquired 
on two different scanners). Following quality control, the regression coefficient, standard error and p-
value for each SNP are forwarded to the coordinating site which conducts a unifying meta-analysis that 
weights the SNP coefficients by their standard-error. This approach circumvents barriers associated with 
data sharing across sites and countries and allows sites to maintain responsibility for the integrity of 
their data. The meta-analysis is performed with an inverse standard-error weighted meta-analysis 
protocol implemented in METAL (Willer et al., 2010). Genomic control of p-values undertaken at the site 
level is repeated on the output of the meta-analysis to provide an additional control for population 
stratification or cryptic relatedness not accounted for by the MDS components (Devlin and Roeder, 
1999). Additionally, associations are verified in replication samples that have been acquired 
independently of the discovery dataset. 
 
Disease Working Groups 
From the time that the pilot project by Stein et al. was published in April 2012, several ENIGMA 
working groups have been formed to focus more closely on applying the ENIGMA meta-analysis 
protocols to case-control differences in various brain-related diseases. With such large studies comes 
the ability to perform high power association studies to identify biomarkers for monitoring disease state 
and targets for drug therapies. ENIGMA working groups have been formed to study ADHD, 
schizophrenia, OCD, HIV, PTSD, major depressive disorder and bipolar disorder (Schmaal et al., 2015; van 
Erp et al., 2015). 
 
ENIGMA Addiction Working Group 
The authors of this review have joined together to leverage the structure of the ENIGMA project to 
study addiction. The international membership represents research laboratories from 4 continents and 9 
different time zones (Figure 2). An initial site survey has identified datasets, including both case/control 
and cohort studies, that collectively contain neuroimaging and genomic data on over 10,000 subjects. 
Table 1 provides a summary of the Addiction working group datasets. The strengths of the working 
group are currently found in several large developmental cohorts as well as case/control studies of 
dependent users of alcohol, nicotine, stimulants (cocaine & methamphetamine) and cannabis.  
Each site has committed to completing the site level analyses through local personnel. ENIGMA 
provides detailed image analysis protocols that will be adopted at all sites 
(http://enigma.ini.usc.edu/protocols/imaging-protocols/). The fact that many sites already employ these 
protocols or very similar processing pipelines will minimize the time required for data preprocessing. 
Data analysis support will be provided by a postdoctoral associate (S.M.) at the University of Vermont 
and will also be available from the engineers and analysts in Dr. Thompson’s ENIGMA support team. 
Easy-to-use instructions on how to preprocess the neuroimaging and genomic data and check for data 
quality have also been prepared.   
A multi-site genetic neuroimaging meta-analysis will only be successful if careful attention is 
paid to the assessment of behavioral variables. The experience of the ENIGMA research consortium 
shows that the pooling of neuroimaging data requires the evaluation, and where possible 
standardization, of site effects on phenotypic characterizations and brain measures. The chosen 
phenotypes and brain measures must offer optimal sensitivity to disease effects, clinically relevant 
modulators of disease, and treatment effects. While each site possesses extensive phenotyping on its 
research participants, there are important differences across sites in the instruments and questionnaires 
used. The Addiction working group will develop common measures of quantity and frequency of use 
derived from the different instruments and assessments obtained at each site. Standardized addiction 
scores will be generated across the varying developmental and clinical profiles. This approach has been 
effective in harmonizing measures of alcohol consumption for the purpose of large genetics studies, 
such as the Gene-Environment Association Studies (GENEVA) consortium. For example, the GENEVA 
consortium was able to convert disparate alcohol measures into useful categories representing onset 
and safe compared with unsafe consumption (Holman and English, 1995; Holman et al., 1996). There are 
many methodological problems associated with measurement heterogeneity for alcohol consumption in 
the context of genomic studies. These include questions with regard to how abstention should be 
interpreted, the episodic nature of alcohol consumption, the coding of current drug use state at the 
time of scanning, the quantity and frequency of substance use across reference periods, differences in 
cultural norms, the standardization of drinking units, as well as recall and other respondent biases (see 
review (Agrawal et al., 2012)). As recommended by Agrawal et al., the Addiction working group will use 
the guidelines and where possible attempt to align the addiction related phenotypes with the NIH PhenX 




The first analysis will examine the structural correlates of four simple drug use categories, no lifetime 
use, occasional use, abuse and dependence. Data related to four substances, i.e. alcohol, nicotine, 
stimulants (cocaine and methamphetamine) and cannabis, will be used to identify the neural substrates 
of core addiction processes as well as substance specific factors. Performing GWAS on the identified 
brain regions will significantly reduce the dimensionality of the brain imaging data. This first analysis will 
establish relationships between the sites and bring to light any major difficulties that need to be 
addressed. Analysis will begin after the first data freeze which will occur at the beginning of May 2015. 
Likely, the most important early challenge for the group will be the development of an assessment 
instrument that harmonizes the different drug use measures at the various sites. 
 
Summary and Future Directions 
Several international consortia have been organized in recent years to improve the statistical power of 
genetic imaging association analyses by pooling data from multiple sites. The authors of this review have 
formed an Addiction working group within the framework of the ENIGMA project to leverage the 
acquired knowledge about data sharing across multiple sites to study the genetic and neurobiological 
mechanisms underlying addiction. The ENIGMA Addiction working group will attempt to identify brain 
endophenotypes starting with a volumetric investigation of the core neural substrates of addiction. The 
identification of core brain regions using structural MRI will reduce the number of dimensions in 
subsequent genomic analyses of problematic substance use. The Addiction working group will adopt the 
meta-analytic methods used successfully by the ENIGMA project. However, a mega-analysis approach, 
i.e. analysis of all pooled raw data at one location, may offer opportunities to conduct in depth 
examinations of the neurobiology of drug use that are not possible in a meta-analysis. While practical 
concerns about sharing data were part of the motivation for the meta-analysis approach used by 
ENIGMA, more sensitive analyses may be possible by going beyond the pooling of effect sizes and the 
sharing of summary statistics (e.g., volume measurements of specific cortical and subcortical structures) 
to the sharing of complete, fully anonymized datasets, where available. We believe that the obstacles to 
this level of data sharing are surmountable. Depending on how the consortium grows (i.e. the addition 
of new members and of new datasets from current members), the Addiction working may in also decide 
to include multi-modal assessments of brain function including task-related and resting state fMRI, DTI 
and EEG (e.g. (Jahanshad et al.; Kochunov et al., 2015)). At the present time, the working group is 
focused on resolving problems related to multi-site data pooling with a manageable number of 18 sites.  
Recent advances in the statistical analysis of genomic data present several promising new ways 
to investigate the combined datasets. We will explore the application of genome-wide complex trait 
analyses (Yang et al., 2011) to assess the heritability and genetic correlations among brain regions and 
phenotypic measures associated with alcohol and drug use. This method produces estimates of the 
variance explained by all SNPs over the whole genome for a complex trait and is suitable for large 
samples of non-related subjects. The working group will also investigate emerging statistical methods to 
detect significant associations in high dimensional data, such as the parallel independent components 
analysis with a reference mask (Liu et al., 2012), meta-analysis of voxel-based data (Jahanshad et al., 
2015) and novel applications of correspondence analysis (Cioli et al., 2014). 
 
Addiction Medicine 
There are multiple ways in which the progress of the working group could impact the practice of 
addiction medicine. Since there is strong evidence that addiction has a genetic component (Maes et al., 
2004; Prescott and Kendler, 1999; Tsuang et al., 1998), a GWAS with sufficient power, such as the one 
envisaged by the working group, will likely detect novel genetic associations with behavioral features of 
addiction or with intermediate brain phenotypes. Not only will these novel associations drive future 
research aimed at understanding the neural processes involved in problematic substance use and 
potentially provide novel targets for pharmacological intervention, but they could also lead to the 
development of predictive genetic and neuroimaging biomarkers. Addiction medicine would benefit 
enormously from a set of predictive tools that could be used to estimate risk at various stages of the 
disorder, e.g. risk of transition from healthy to problematic patterns of use or risk of relapse after 
treatment (Paulus, 2015). Current research also points towards a heterogeneity of causes (Tsuang et al., 
1998). If addictive behavior can be attributed to many small effects in a range of brain systems, it is 
possible that combined neuroimaging and genetic testing could identify differential vulnerabilities which 
could be used to customize treatment to address the specific challenges of the individual patient. 
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Tables and Figures 
 





















Cases & Ctrls  
Alcohol Occasional 150 75 150 
 Dependent 1695 560 2124 
 Abstinent 61 24 177 
Nicotine Occasional  0 0 0 
 Current 1132 385 1797 
 Abstinent 10 0 10 
Cannabis Occasional 91 30 213 
 Dependent 238 33 348 
 Abstinent 17 7 34 
Stimulants Occasional 175 69 228 
 Dependent 906 182 1408 
 Abstinent 68 9 108 
Gambling Occasional 0 0 0 
 Dependent 59 0 187 
 Abstinent 0 0 0 
Heroin Occasional 0 0 0 
 Dependent 0 0 0 























Figure 1. Illustration of a structural MRI brain scan processed with FreeSurfer. Left, example of 










Figure 2. World map of the current membership of the ENIGMA Addiction working group.  
